Table 2.
Outcomes by clinic with the chi-square test or t-test.
| Covariate | GI clinic (n = 192) before SVR | PCP clinic (n = 185) before SVR | Parametric p value∗ | GI clinic (n = 192) at SVR | PCP clinic (n = 185) at SVR | Parametric p value∗ |
|---|---|---|---|---|---|---|
| Patients achieving SVR, n (%) | 184 (95.83%) | 173 (93.51%) | 0.32 | |||
| MELD score, mean (range) | 7.32 (6.96-7.68) | 7.87 (7.39-8.34) | 0.27 | 8.50 (6.00-26.00) | 8.41 (6.00-24.00) | 0.93 |
| CTP score, mean (range) | 5.08 (5.03-5.13) | 5.14 (5.09-5.20) | 0.08 | 5.39 (5.00-11.00) | 5.22 (5.00-8.00) | 0.44 |
| Fib-4 score, mean (range) | 1.83 (1.71-1.95) | 1.96 (1.84-2.07) | 0.14 | 1.80 (0.53-13.14) | 1.63 (0.69-5.18) | 0.19 |
| ALT, mean (range) | 56.41 (50.04-62.79) | 49.55 (44.51-54.60) | 0.10 | 21.87 (6.00-60.00) | 22.99 (7.00-173.00) | 0.44 |
| AST, mean (range) | 45.97 (42.04-49.91) | 45.51 (42.16-48.87) | 0.86 | 25.87 (14.00-83.00) | 27.29 (10.00-89.00) | 0.25 |
| Hemoglobin, mean (range) | 14.86 (14.66-15.06) | 14.84 (14.60-1t5.08) | 0.91 | 14.71 (8.30-17.80) | 14.65 (10.90-18.70) | 0.75 |
| T. bilirubin, mean (range) | 0.80 (0.75-0.84) | 0.75 (0.70-0.79) | 0.10 | 0.71 (0.20-4.60) | 0.65 (0.10-2.30) | 0.18 |
| Albumin, mean (range) | 4.03 (3.98-4.07) | 3.91 (3.85-3.97) | <0.01 | 3.99 (1.21-5.00) | 4.00 (0.30-4.90) | 0.98 |
| Na, mean (range) | 138.1 (137.8-138.5) | 136.9 (136.5-137.4) | <0.01 | 137.7 (128.0-143.0) | 137.2 (127.0-143.0) | 0.08 |
| Reported HCC posttherapy, n (%) | 1 (0.52%) | 1 (0.54%) | 1.00 |
Abbreviations: GI: gastroenterology; PCP: primary care physician; SVR: sustained virological response; MELD: Model for End-Stage Liver Disease; CTP: Child-Turcotte-Pugh; AST: aspartate aminotransferase; ALT: alanine aminotransferase; HCC: hepatocellular carcinoma.